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Abstract
IMPORTANCE Increased levels of ambient fine particulate matter (PM2.5) air pollution are
associated with increased risks for detrimental health outcomes, but risks for patients with kidney
transplants (KTs) remain unknown.
OBJECTIVE To investigate the association of PM2.5 exposure with KT outcomes.
DESIGN, SETTING, AND PARTICIPANTS This retrospective cohort study was conducted using data
on patients who received KTs from 2004 to 2016 who were identified in the national US transplant
registry and followed up through March 2021. Multiple databases were linked to obtain data on PM2.5
concentration, KT outcomes, and patient clinical, transplant, and contextual factors. Data were
analyzed from April 2020 through July 2021.
EXPOSURES Exposures included post-KT time-dependent annual mean PM2.5 level (in 10 μg/m3)
and mean PM2.5 level in the year before KT (ie, baseline levels) in quartiles, as well as baseline annual
mean PM2.5 level (in 10 μg/m
3).
MAIN OUTCOMES AND MEASURES Acute kidney rejection (ie, rejection within 1 year after KT),
time to death-censored graft failure, and time to all-cause death. Multivariable logistic regression for
kidney rejection and Cox analyses with nonlinear assessment of exposure-response for death-
censored graft failure and all-cause death were performed. The national burden of graft failure
associated with PM2.5 levels greater than the Environmental Protection Agency recommended level
of 12 μg/m3 was estimated.
RESULTS Among 112 098 patients with KTs, 70 522 individuals (62.9%) were older than age 50
years at the time of KT, 68 117 (60.8%) were men, and the median (IQR) follow-up was 6.0 (3.9-8.9)
years. There were 37 265 Black patients (33.2%), 17 047 Hispanic patients (15.2%), 48 581 White
patients [43.3%]), and 9205 patients (8.2%) of other race or ethnicity. The median (IQR) baseline
PM2.5 level was 9.8 (8.3-11.9) μg/m
3. Increased baseline PM2.5 level, compared with quartile 1 baseline
PM2.5 level, was not associated with higher odds of acute kidney rejection for quartile 2 (adjusted
odds ratio [aOR], 0.99; 95% CI, 0.92-1.06) but was associated with increased odds for quartile 3
(aOR, 1.11; 95% CI, 1.04-1.20) and quartile 4 (aOR, 1.13; 95% CI, 1.05-1.23). Nonlinear assessment of
exposure-response for graft failure and death showed no evidence for nonlinearity. Increased PM2.5
levels were associated with increased risk of death-censored graft failure (adjusted hazard ratio
[aHR] per 10 μg/m3 increase, 1.17; 95% CI, 1.09-1.25) and all-cause death (aHR per 10 μg/m3 increase,
1.21; 95% CI, 1.14-1.28). The national burden of death-censored graft failure associated with PM2.5




Question Is exposure to increased
levels of ambient fine particulate matter
(PM2.5) air pollution associated with
increased risk of adverse posttransplant
outcomes among patients with kidney
transplants?
Findings In this cohort study of 112 098
patients with kidney transplants,
increased PM2.5 concentration was
associated with increased risk of adverse
posttransplant outcomes, including
acute rejection, graft failure, and death.
Meaning These findings suggest that
health outcomes associated with air
pollution may extend to serious adverse
clinical outcomes among patients with
kidney transplants.
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Abstract (continued)
CONCLUSIONS AND RELEVANCE This cohort study found that PM2.5 level was an independent risk
factor associated with acute rejection, graft failure, and death among patients with KTs. These
findings suggest that efforts toward decreasing levels of PM2.5 concentration may be associated with
improved outcomes after KT.
JAMA Network Open. 2021;4(10):e2128190. doi:10.1001/jamanetworkopen.2021.28190
Introduction
Increased levels of ambient air pollution (ie, fine particulate matter 2.5 μm or less in aerodynamic
diameter [PM2.5]) are associated with an increased risk of detrimental health outcomes, including
cardiovascular disease, diabetes, and all-cause mortality.1-6 The underlying mechanisms for these
associations may include associations of inhaled particulate matter with increased sympathetic
vascular modulation, intravascular thrombosis, and promotion of atherosclerosis.7,8 A dose-response
association has also been reported.9 Furthermore, Dockery et al10 found that improvements in air
quality, with decreases in PM2.5 levels, were associated with a decrease in mortality risk.
In the field of kidney disease, epidemiological studies from 2016 to 202011-13 have found that
increased levels of PM2.5 are associated with increased risk for decline in kidney functions, including
decreased estimated glomerular filtration rate (eGFR) and increased rates of chronic kidney disease
(CKD) and end-stage kidney disease. The etiology of kidney disease may be mediated by an increase
in systemic inflammation and oxidative stress associated with air pollutants.14,15 It also has been
found that particulate matter inhaled through the respiratory tract and cleared by the kidney may be
associated with direct damage to renal tissue.16 Furthermore, air pollutants and PM2.5 are associated
with insulin resistance,17,18 attenuated flow-mediated arterial dilation,19 and systemic
hypertension,20-22 which are important factors that may be associated with kidney function.
Despite the existing evidence for an association between PM2.5 levels and health outcomes, few
studies have examined the association between PM2.5 levels and the outcomes of solid organ
transplantation. Among patients with lung transplants, Bhinder et al23 found that increased PM2.5
levels were associated with an increased risk of chronic lung allograft dysfunction and overall
mortality. Similar findings have been observed among individuals with heart transplants.24 Among
individuals with kidney transplant (KT), studies25,26 found that exposure to air pollutants was
associated with an increased risk of cardiovascular mortality, but associations of PM2.5 levels with
other important transplant outcomes have not been examined to date, to our knowledge. With the
identified knowledge gap in the association of PM2.5 levels with KT outcomes, this study aimed to
determine whether PM2.5 concentration is an independent risk factor associated with kidney
rejection, graft failure, or overall mortality among patients with KTs.
Methods
Exemptions for study approval and informed consent were obtained for this cohort study from the
Washington University in St. Louis School of Medicine Institutional Review Board because the study
was secondary analyses of deidentified data. This report follows the Strengthening the Reporting of
Observational Studies in Epidemiology (STROBE) reporting guideline for cohort studies.
Study Design and Data
A retrospective cohort of patients who received KTs from 2004 to 2016 was obtained from the
Organ Procurement and Transplantation Network (OPTN). Transplant outcomes were followed up
until March 2021. Detailed descriptions of OPTN data were described elsewhere.27,28 Briefly, the
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database contains national data on the candidate waiting list, organ donation and matching, and
transplantation.29
We obtained recipient characteristics, including age, sex, race and ethnicity (as reported by
transplant centers in electronic health records), body mass index (BMI; calculated as weight in
kilograms divided by height in meters squared), insurance status, and zip code of residence at the
time of KT, as well as clinical data on panel reactive antibodies (PRA), diabetes, chronic obstructive
pulmonary disease, etiology of kidney disease, and duration of dialysis closest to transplant. Race and
ethnicity were among the many recipient and donor characteristics (eg, age and sex) that we used
to adjust for recipient and donor characteristics. We also collected donor characteristics, including
age, sex, race and ethnicity, BMI, kidney donor profile index, donor type, and history of hypertension,
as well as transplant factors, including donor-recipient cytomegalovirus seropairing, level of human
leukocyte antigen (HLA) mismatch, and cold ischemia time. Patient zip codes of residence were
mapped to zip code–level data to obtain contextual characteristics, including area deprivation index
(ADI), population density (measured as number of individuals per square meter), median income,
high school graduation and unemployment rates, and proportion of residents below the federal
poverty line. Data on ADI were obtained from the University of Wisconsin School of Medicine and
Public Health’s Neighborhood Atlas.30,31 ADI summarizes factors for the theoretical domains of
income, education, employment, and housing quality.32 Data on population density were obtained
from the US Bureau of Census 2010 Zip Code Tabulation Area to tract Relationship File.33 Data on
remaining contextual characteristics were obtained from 2011 to 2015 American Community Survey
5-year estimates accessed through ArcGIS Living Atlas of the World.34
Exposure
The exposure was post-KT time-dependent annual mean PM2.5 concentration in micrograms per
cubic meter in the recipient residential zip code area to reflect changing levels of PM2.5 over time
after KT. Data on annual mean PM2.5 concentration (1 × 1 km) in the contiguous United States were
obtained from aerosol optical depth retrievals from the NASA Moderate Resolution Imaging
Spectroradiometer, Multi-Angle Imaging Spectroradiometer, and Sea-Viewing Wide Field-of-View
Sensor calibrated using geographically weighted regression.35,36 The years of availability were 2001
to 2018. The overlap of 1 × 1–km resolution PM2.5 grids and zip code area produced surface area–
weighted PM2.5 levels for each zip code.
11
Baseline PM2.5 level, defined as the annual mean PM2.5 level in the year before KT for a patient’s
residential zip code area, was also considered as baseline PM2.5 level in 10 μg/m
3 increments and
baseline PM2.5 level categorized in quartiles.
Outcomes
The outcomes included acute kidney rejection reported at 1 year after KT (yes or no), death-censored
graft failure (yes or no; if yes, time from KT to graft failure), and all-cause death (yes or no; if yes, time
from KT to patient death), with all data from the OPTN. The latter 2 transplant outcomes were
followed up until March 2021 unless otherwise specified.
Analytic Cohort
The cohort included patients who underwent KT from 2004 to 2016. We excluded patients aged
younger than 18 years at KT, patients receiving kidneys from living donors, patients with a previous
KT, and patients with missing data on zip codes or continuous covariate variables.
Statistical Analysis
Recipient characteristics, donor characteristics, transplant factors, and contextual factors were
stratified by baseline PM2.5 level quartiles in percentages for categorical variables and in medians
(IQRs) for continuous variables. To compare between baseline PM2.5 level quartiles, χ
2 tests were
performed for categorical variables and Kruskal-Wallis tests were performed for continuous
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variables. Survival curves for time-to-event transplant outcomes (ie, death-censored graft failure and
all-cause death) stratified by baseline PM2.5 level quartiles were adjusted for recipients' age, sex, race
and ethnicity, dialysis status and duration, and ADI.
The associations of post-KT PM2.5 concentration with time-to-event transplant outcomes were
analyzed by multivariable Cox models. Robust sandwich variance estimators for Cox models were
used.37,38 Follow-up was censored at the end of 2018 because data on annual mean PM2.5
concentration were available only up to 2018. The covariates in these multivariable models were
selected from all recipient demographics, donor characteristics, transplant factors, contextual factors
(see Table for included variables), and year of KT using the forward-selection algorithm with a
stopping rule informed by Akaike information criterion (smallest). Year of KT was included in all
analyses to account for decreasing annual mean PM2.5 concentration over time. The same analyses
were repeated for the association of baseline PM2.5 exposures with time-to-event transplant
outcomes. Association of baseline PM2.5 level quartiles with the binary transplant outcome (ie, acute
kidney rejection) was analyzed using multivariable logistic regression.
To plot the exposure-response function for death-censored graft failure and all-cause death,
cubic spline analyses were first performed in multivariable Cox models with knots placed at baseline
PM2.5 level quartiles,
39 and the statistical significance of spline terms was assessed for nonlinearity
of spline terms. When there was no evidence of deviation from linearity, patients residing in areas
with the lowest 1% (ie, 3.7 μg/m3) and the highest 1% (ie, 16.9 μg/m3) baseline PM2.5 levels were
excluded from the analytic cohort, and multivariable-adjusted hazard ratios using the
aforementioned Cox models were estimated using 3.7 μg/m3 as the reference level. These
multivariable-adjusted hazard ratios (HRs) were plotted against the baseline PM2.5 level from 3.7
μg/m3 to 16.9 μg/m3 with the background of the histogram distribution of baseline PM2.5 level for the
included analytic cohort.11
Geographic distribution of the estimated national burden of graft failure associated with PM2.5
levels greater than the Environmental Protection Agency (EPA) recommended PM2.5 concentration
of 12 μg/m3 was plotted using the population attributable fraction (PAF) multiplied by incidence of
graft failure per 100 000 patients with KTs per year from 2004 to 2016. PAF was the proportional
reduction of the condition in the KT population that would occur if exposure to PM2.5 was decreased
to 12 μg/m3. PAF was computed using piecewise constant hazard models for graft failure
incidence.11,40,41
All tests were 2-sided, and results were considered statistically significant at α = .05 or when
95% CIs did not cross 1 for odds ratios and hazard ratios. All statistical analyses were performed using
SAS statistical software version 9.4 (SAS Institute) and R statistical software version 4.0.2 (R Project
for Statistical Computing). Zip code–level PM2.5 concentration was computed using ArcGIS Pro
software version 2.7.0 (Esri). Data were analyzed from April 2020 through July 2021.
To account for variations in city characteristics that could confound the association, sensitivity
analyses for all 3 outcomes were conducted using multilevel models and adapting city-adjusted and
within-city models. These models were detailed elsewhere.5,11 Cities were defined as core-based
(including metropolitan and micropolitan) statistical areas, which were obtained from the US Census
Bureau33 and linked to patient residential zip codes. Additionally, for the acute kidney rejection
outcome, multivariable logistic regression was performed adjusting for city clustering.
Results
Among 214 317 patients who received KTs from 2004 to 2016 in the United States (eFigure in the
Supplement), we excluded 9338 patients aged younger than 18 years at KT, 71 536 patients receiving
kidneys from living donors, 14 650 patients with a previous KT, 6573 patients with missing residential
zip codes, and 122 patients with missing data on at least 1 continuous variable. The resulting analytic
cohort included 112 098 patients with KTs. The median (IQR) follow-up was 6.0 (3.9-8.9) years;
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Table. Recipient and Donor Characteristics and Transplant and Contextual Factors by Quartile
Variable Overall (N = 112 098)
Patients by PM2.5 concentration quartile, No. (%)a
P valueQuartile 1 (n = 28 025)b Quartile 2 (n = 28 024 )c Quartile 3 (n = 28 025)d Quartile 4 (n = 28 024)e
Recipient characteristic
Age, y
18-50 41 576 (37.09) 9612 (34.30) 10 360 (36.97) 10 622 (37.90) 10 982 (39.19)
<.001
>50 70 522 (62.91) 18 413 (65.70) 17 664 (63.03) 17 403 (62.10) 17 042 (60.81)
Sex
Women 43 981 (39.23) 10 956 (39.09) 11 175 (39.88) 10 968 (39.14) 10 882 (38.83)
.07
Men 68 117 (60.77) 17 069 (60.91) 16 849 (60.12) 17 057 (60.86) 17 142 (61.17)
Race and ethnicity
Black 37 265 (33.24) 5148 (18.37) 9572 (34.16) 11 202 (39.97) 11 343 (40.48)
<.001
Hispanic 17 047 (15.21) 4323 (15.43) 4130 (14.74) 3537 (12.62) 5057 (18.05)
White 48 581 (43.34) 15 765 (56.25) 12 099 (43.17) 11 255 (40.16) 9462 (33.76)
Otherf 9205 (8.21) 2789 (9.95) 2223 (7.93) 2031 (7.25) 2162 (7.71)
BMI
<18.5 38 083 (1.82) 9555 (1.66) 9459 (1.78) 9453 (1.72) 9616 (2.13)
<.001
18.5 to <25 2043 (28.52) 465 (27.8) 498 (27.18) 482 (28.12) 598 (30.97)
25 to <30 31 967 (33.97) 7790 (34.09) 7618 (33.75) 7881 (33.73) 8678 (34.31)
≥30 39 684 (35.4) 10 192 (36.37) 10 423 (37.19) 10 138 (36.17) 8931 (31.87)
Missing 321 (0.29) 23 (0.08) 26 (0.09) 71 (0.25) 201 (0.72)
Insurance
Public 82 763 (73.83) 20 870 (74.47) 21 050 (75.11) 20 531 (73.26) 20 312 (72.48)
<.001Private 29 197 (26.05) 7127 (25.43) 6948 (24.79) 7460 (26.62) 7662 (27.34)
Other 138 (0.12) 28 (0.1) 26 (0.09) 34 (0.12) 50 (0.18)
PRA, %
0 67 298 (60.03) 17 668 (63.04) 16 986 (60.61) 16 746 (59.75) 15 898 (56.73)
<.001
>0 to 20 17 170 (15.32) 3516 (12.55) 3776 (13.47) 4361 (15.56) 5517 (19.69)
>20-80 16 202 (14.45) 4093 (14.60) 4298 (15.34) 4088 (14.59) 3723 (13.29)
>80 10 063 (8.98) 2594 (9.26) 2808 (10.02) 2555 (9.12) 2106 (7.51)
Missing 1365 (1.22) 154 (0.55) 156 (0.56) 275 (0.98) 780 (2.78)
Dialysis time, mo
0 13 137 (11.72) 3543 (12.64) 3204 (11.43) 3251 (11.6) 3139 (11.20)
<.001
<24 15 708 (34.15) 4117 (35.38) 3781 (34.61) 3895 (34.36) 3915 (32.24)
24-60 38 281 (14.01) 9915 (14.69) 9700 (13.49) 9630 (13.90) 9036 (13.97)
>60 31 544 (28.14) 7272 (25.95) 8211 (29.3) 7691 (27.44) 8370 (29.87)
Missing 13 428 (11.98) 3178 (11.34) 3128 (11.16) 3558 (12.70) 3564 (12.72)
Etiology of kidney
disease
Diabetes 32 854 (29.31) 8663 (30.91) 8424 (30.06) 8126 (29.00) 7641 (27.27)
<.001
Glomerulonephritis 12 482 (11.13) 3294 (11.75) 3050 (10.88) 3097 (11.05) 3041 (10.85)
Hypertension 30 562 (27.26) 5616 (20.04) 7549 (26.94) 8245 (29.42) 9152 (32.66)
Polycystic kidney
disease
9346 (8.34) 2756 (9.83) 2385 (8.51) 2261 (8.07) 1944 (6.94)
Other 26 283 (23.45) 7546 (26.93) 6483 (23.13) 6162 (21.99) 6092 (21.74)
Missing 571 (0.51) 150 (0.54) 133 (0.47) 134 (0.48) 154 (0.55)
Diabetes
Yes 41 353 (36.89) 10 497 (37.46) 10 559 (37.68) 10 420 (37.18) 9877 (35.24)
<.001No 69 850 (62.31) 17 425 (62.18) 17 377 (62.01) 17 405 (62.11) 17 643 (62.96)
Missing 895 (1.16) 103 (0.51) 88 (0.53) 200 (1.48) 504 (2.09)
Chronic obstructive
pulmonary disease
Yes 1469 (1.31) 434 (1.55) 390 (1.39) 379 (1.35) 266 (0.95)
<.001No 101 205 (90.28) 24 103 (86.01) 25 103 (89.58) 25 902 (92.42) 26 097 (93.12)
Missing 9424 (8.41) 3488 (12.45) 2531 (9.03) 1744 (6.22) 1661 (5.93)
(continued)
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Table. Recipient and Donor Characteristics and Transplant and Contextual Factors by Quartile (continued)
Variable Overall (N = 112 098)
Patients by PM2.5 concentration quartile, No. (%)a
P valueQuartile 1 (n = 28 025)b Quartile 2 (n = 28 024 )c Quartile 3 (n = 28 025)d Quartile 4 (n = 28 024)e
Donor characteristic
Age, y
<18 11 266 (10.05) 2697 (10.05) 2848 (10.05) 2812 (10.05) 2909 (10.05)
<.00118-50 69 483 (61.98) 17 690 (63.12) 17 581 (62.74) 17 453 (62.28) 16 759 (59.80)
>50 31 349 (27.97) 7638 (27.25) 7595 (27.10) 7760 (27.69) 8356 (29.82)
KDPI, %
<0.25 34 606 (30.87) 9430 (33.65) 8669 (30.93) 8437 (30.11) 8070 (28.80)
<.001
0.25-0.50 31 471 (28.07) 8022 (28.62) 8097 (28.89) 7890 (28.15) 7462 (26.63)
0.51-0.84 36 289 (32.37) 8661 (30.9) 9075 (32.38) 9218 (32.89) 9335 (33.31)
≥0.85 9051 (8.07) 1811 (6.46) 2061 (7.35) 2302 (8.21) 2877 (10.27)
Missing 681 (0.61) 101 (0.36) 122 (0.44) 178 (0.64) 280 (1.00)
Sex
Women 44 814 (39.98) 11 073 (39.51) 11 235 (40.09) 11 277 (40.24) 11 229 (40.07)
.31
Men 67 284 (60.02) 16 952 (60.49) 16 789 (59.91) 16 748 (59.76) 16 795 (59.93)
Race and ethnicity
Black 15 550 (13.87) 2814 (10.04) 4028 (14.37) 4317 (15.4) 4391 (15.67)
Hispanic 15 189 (13.55) 3836 (13.69) 3711 (13.24) 3226 (11.51) 4416 (15.76)
White 77 508 (69.14) 20 268 (72.32) 19 373 (69.13) 19 684 (70.24) 18 183 (64.88)
Otherf 3851 (3.44) 1107 (3.95) 912 (3.25) 798 (2.85) 1034 (3.69)
BMI
<18.5 6616 (5.90) 1572 (5.61) 1698 (6.06) 1571 (5.61) 1775 (6.33)
<.001
18.5-24.9 38 504 (34.35) 9482 (33.83) 9462 (33.76) 9704 (34.63) 9856 (35.17)
25-29.9 34 735 (30.99) 8807 (31.43) 8568 (30.57) 8636 (30.82) 8724 (31.13)
≥30 32 082 (28.62) 8128 (29) 8263 (29.49) 8081 (28.83) 7610 (27.16)
Missing 161 (0.14) 36 (0.13) 33 (0.12) 33 (0.12) 59 (0.21)
Hypertension
No 80 582 (71.89) 20 594 (73.48) 20 161 (71.94) 19 967 (71.25) 19 860 (70.87)
<.001




D-, R- 11 032 (9.84) 2813 (10.04) 2713 (9.68) 2931 (10.46) 2575 (9.19)
<.001
R+ 61 398 (54.77) 12 174 (43.44) 13 872 (49.5) 16 967 (60.54) 18 385 (65.60)
D+, R- 16 592 (14.8) 3931 (14.03) 4240 (15.13) 4318 (15.41) 4103 (14.64)
Missing 23 076 (20.59) 9107 (32.5) 7199 (25.69) 3809 (13.59) 2961 (10.57)
HLA mismatch
0 8128 (7.25) 1912 (6.82) 1776 (6.34) 1892 (6.75) 2548 (9.09)
<.0011-2 6024 (5.37) 1574 (5.62) 1487 (5.31) 1403 (5.01) 1560 (5.57)
3-6 97 067 (86.59) 24360 (86.92) 24 603 (87.79) 24 517 (87.48) 23 587 (84.17)
Missing 879 (0.78) 179 (0.64) 158 (0.56) 213 (0.76) 329 (1.17)
Cold ischemia, h
<12 32 542 (29.03) 9132 (32.59) 8346 (29.78) 8294 (29.60) 6770 (24.16)
<.001
12-24 54 649 (48.75) 13 514 (48.22) 13 497 (48.16) 13 692 (48.86) 13 946 (49.76)
>24 21 068 (18.79) 4752 (16.96) 5265 (18.79) 5198 (18.55) 5853 (20.89)




53.7 (31.12-72.32) 53.27 (34.29-70.38) 55.15 (33.04-72.33) 56.93 (33.95-75.15) 47.01 (24.21-71.05) <.001
High school graduates,
median (IQR), %
60.05 (51.80-65.82) 62.24 (55.43-67.40) 60.34 (52.45-65.82) 59.55 (51.11-65.71) 57.2 (48.86-63.87) <.001
Household income,
median (IQR), $
51 596 (40 731-66 575) 53 006 (43 655-66 637) 52 122 (41 203-67 840) 50 750 (39 249-66 655) 50 243 (38 450-65 088) <.001
(continued)
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70 522 individuals (62.9%) were older than age 50 years at the time of KT and 68 117 (60.8%) were
men (Table).
Most patients were White (48 581 patients [43.3%]), while 37 265 patients (33.2%) were Black,
17 047 patients (15.2%) were Hispanic, and 9205 patients (8.2%) were of other race or ethnicity.
Most patients had obesity or overweight BMI and were on dialysis more than 24 months before KT.
Most patients received kidneys from donors who were aged 18 to 50 years (69 483 patients
[62.0%]), men (67 284 patients [60.0%]), and White (77 508 individuals [69.1%]), while 15 550
patients had donors who were Black (14.0%), 15 189 patients had donors who were Hispanic (14.0%),
and 3851 patients had donors who were of other race or ethnicity (3.4%). Most patients received
kidneys from donors with a BMI from 18.5 to 24.9 (38 504 patients [34.4%]) or 25.0 to 29.9 (34 735
patients [30.99%]). Among transplant factors, most patients had a level of HLA mismatch of 3 to 6
hours and 12 to 24 hours of cold ischemia time. The median (IQR) ADI of patient residential zip code
areas was 53.7 (31.1-72.3), and the median (IQR) population density was 0.00076
(0.00013-0.00186) individuals per square meter.
The median (IQR) baseline PM2.5 level was 9.8 (8.3-11.9) μg/m
3. Baseline PM2.5 concentration
ranged from 1.2 μg/m3 to less than 8.3 μg/m3 among 28 025 patients in the first quartile, from 8.3
μg/m3 to less than 9.8 μg/m3 among 28 024 patients in the second quartile, from 9.8μg/m3 to less
than 11.9 μg/m3 among 28 025 patients in the third quartile, and from 11.9 μg/m3to less than 22.4
μg/m3 among 28 024 patients in the fourth quartile. All recipient demographics, donor
characteristics, transplant factors, and contextual factors were statistically significantly different
across PM2.5 level quartiles except for sex for recipients and donors. Factors that decreased with
PM2.5 level quartiles included proportion of recipients aged older than 50 years (quartile 1: 18 413
patients [65.7%]; quartile 2: 17 664 patients [63.0%]; quartile 3: 17 403 patients [62.1%]; quartile 4:
Table. Recipient and Donor Characteristics and Transplant and Contextual Factors by Quartile (continued)
Variable Overall (N = 112 098)
Patients by PM2.5 concentration quartile, No. (%)a
P valueQuartile 1 (n = 28 025)b Quartile 2 (n = 28 024 )c Quartile 3 (n = 28 025)d Quartile 4 (n = 28 024)e
Income below poverty
level, median (IQR), %
15.67 (10.03-23.02) 13.9 (9.30-19.62) 15.32 (9.65-22.14) 16.21 (10.15-24.35) 18.37 (11.43-26.45) <.001
Unemployment, median
(IQR), %


















5.95 (3.85-8.90) 5.02 (3.70-7.23) 5.48 (3.82-7.89) 6.61 (3.98-9.04) 7.33 (3.96-10.92) <.001
Acute kidney rejection
Yes 7793 (6.95) 1762 (6.29) 1821 (6.50) 2105 (7.51) 2105 (7.51)
<.001No 79 048 (70.52) 20 382 (72.73) 20 089 (71.68) 19 536 (69.71) 19 041 (67.95)
Missing 25 257 (22.53) 5881 (20.98) 6114 (21.82) 6384 (22.78) 6878 (24.54)
Death-censored graft
failure
Yes 18 652 (16.64) 2974 (10.61) 3831 (13.67) 5104 (18.21) 6743 (24.06)
<.001
No 93 446 (83.36) 25 051 (89.39) 24 193 (86.33) 22 921 (81.79) 21 281 (75.94)
All-cause death
Yes 27 826 (24.82) 5047 (18.01) 5670 (20.23) 7336 (26.18) 9773 (34.87)
<.001
No 84 272 (75.18) 22 978 (81.99) 22 354 (79.77) 20 689 (73.82) 18 251 (65.13)
Abbreviations: BMI, body mass index (calculated as weight in kilograms divided by
height in meters squared); CMV, cytomegalovirus; HLA, human leukocyte antigen; KDPI,
kidney donor profile index; PM2.5, fine particulate matter air pollution.
a Patients are stratified by annual mean PM2.5 concentration in the year before kidney
transplant (ie, baseline PM2.5 level) for patients receiving kidney transplant from 2004
to 2016.
b PM2.5 level = 1.2 μg/m3 to less than 8.3 μg/m3.
c PM2.5 level = 8.3 μg/m3 to less than 9.8 μg/m3.
d PM2.5 level = 9.8 μg/m3 to less than 11.9 μg/m3.
e PM2.5 level = 11.9 μg/m3 to less than 22.4 μg/m3.
f The other race and ethnicity group includes Asian individuals, American Indian or
Alaska Native individuals, Native Hawaiian or other Pacific Islander individuals, and
individuals of multiple races or ethnicities.
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17 042 patients [60.8%]; P < .001) and the proportion who were White (quartile 1: 15 765 White
individuals [56.3%]; 5148 Black individuals [18.4%]; 4323 Hispanic individuals [15.4%]; 2789
individuals with other race or ethnicity [10.0%]; quartile 2: 12 099 White individuals [43.2%]; 9572
Black individuals [34.2%]; 4130 Hispanic individuals [14.7%]; 2223 individuals with other race or
ethnicity [7.9%]; quartile 3: 11 255 White individuals [40.2%]; 11 202 Black individuals [40.0%]; 3537
Hispanic individuals [12.6%]; 2031 individuals with other race or ethnicity [7.3%]; quartile 4: 9462
White individuals [33.8%]; 11 343 Black individuals [40.5%]; 5057 Hispanic individuals [18.1%]; 2162
individuals with other race or ethnicity [7.7%]; P < .001) (Table).
Other factors that decreased by quartile included diabetes as a comorbidity, hypertension as
etiology of kidney disease, PRA of 0%, and public insurance, as well as proportion of KTs with cold
ischemia time less than 12 hours. Patients receiving KTs in earlier years were more likely to be in the
fourth quartile, and patients receiving KTs in more recent years were more likely to be in the first
quartile, as suggested by the increased follow-up time with quartiles in Table. Increased baseline
PM2.5 levels by quartile were associated with increases in acute kidney rejection (quartile 1: 1762
patients [6.3%]; quartile 3: 1821 patients [6.5%]; quartile 3: 2105 patients [7.5%]; quartile 4: 2105
patients [7.5%]; P < .001), death-censored graft failure (quartile 1: 2974 patients [10.6%]; quartile 2:
3831 patients [13.7%]; quartile 3: 5104 patients [18.2]; quartile 4: 6743 patients [24.1%]; P < .001),
and all-cause death (quartile 1: 5047 patients [18.0%]; quartile 2: 5670 patients [20.2%]; quartile 3:
7336 patients [26.2%]; quartile 4: 9773 patients [34.9%]; P < .001) (Table). The adjusted survival
curves on death-censored graft failure and all-cause death, stratified by baseline PM2.5 level quartiles
(Figure 1A-B) demonstrated a similar pattern.
In multivariable analyses (Figure 2), compared with quartile 1 of baseline PM2.5 level (Figure 2A),
the odds of acute kidney rejection did not increase statistically significantly for quartile 2 (adjusted
odds ratio [aOR], 0.99; 95% CI, 0.92-1.06) but did for quartile 3 (aOR, 1.11; 95% CI, 1.04-1.20) and
quartile 4 (aOR, 1.13; 95% CI, 1.05-1.23). For the exposure response function, cubic spline analyses
suggested no evidence of nonlinear association between PM2.5 concentration and risks for death-
censored graft failure or all-cause death. These analyses are presented in Figure 3 with the
background of the histogram distribution of the baseline PM2.5 level.
Risks for adverse KT outcomes increased with levels of post-KT time-dependent PM2.5 (death-
censored graft failure: adjusted hazard ratio [aHR] per 10 μg/m3 increase, 1.17; 95% CI, 1.09-1.25;
all-cause death: aHR per 10 μg/m3 increase, 1.21; 95% CI, 1.14-1.28) (Figure 2B left). Using baseline
PM2.5 level by quartile as exposure, we found that increased baseline PM2.5 level, compared with
baseline PM2.5 level at quartile 1, was associated with increased risk for death-censored graft failure
(quartile 2: aHR, 1.08; 95% CI, 1.02-1.13; quartile 3: aHR, 1.13; 95% CI, 1.08-1.18; quartile 4: aHR, 1.19;
95% CI, 1.14-1.26) and all-cause death (quartile 2: aHR, 1.07; 95% CI, 1.03-1.11; quartile 3: aHR, 1.09;
95% CI, 1.05-1.13; quartile 4: aHR, 1.16; 95%, CI, 1.12-1.21). Using continuous baseline PM2.5 exposure
(Figure 2B, right), increased PM2.5 levels were associated with increased odds for the 3 KT outcomes
per 10 μg/m3 increase in PM2.5 concentration (rejection: aOR, 1.16; 95% CI, 1.04-1.28; graft failure:
aHR, 1.20; 95% CI, 1.13-1.28; death: aHR, 1.21; 95% CI, 1.15-1.27).
The PAF for graft failure if exposure to PM2.5 was reduced to the EPA recommended level of 12
μg/m3 was 3.99% (95% CI 3.32%-4.65%). The national burden of graft failure associated with
increased levels of PM2.5 over 12 μg/m
3 was estimated to be 57 failures (95% uncertainty interval, 48
failures-67 failures) among 8623 patients with KTs per year from 2004 to 2016. The map illustrating
the geographic distribution of the burden of graft failure (per 100 000 patients with KTs) associated
with increased levels of PM2.5 over 12 μg/m
3 is presented in Figure 4. The burden increased with the
darkness of the color, and the areas with gray color indicate that no patients in the analytic cohort
resided in those areas at the time of their KTs. In sensitivity analyses adjusting for variations in city
characteristics, we found that, compared with quartile 1 of the baseline PM2.5 level, increased
baseline PM2.5 level quartiles were associated with increased risk of acute kidney rejection, graft
failure, and all-cause death (eTable in the Supplement).
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Discussion
This cohort study is one of the first studies, to our knowledge, to assess the association of ambient
fine particulate matter air pollution with outcomes among recipients of KTs. Using annual mean
PM2.5 concentration during post-KT follow-up or in the year before KT (by quartile or quantity), our
study consistently found that PM2.5 concentration was an independent risk factor associated with
acute rejection, death-censored graft failure, and all-cause mortality among recipients of KTs. These
results were robust when different statistical models (with or without adjustment for city variations)
were used. We also found linear exposure response associations between baseline PM2.5
concentration and risks for death-censored graft failure and all-cause death. These findings suggest
that consistent exposure to fine particulate matter air pollution is associated with increased risk of
worse transplant outcomes among recipients of KTs, including kidney rejection, kidney graft failure,
and all-cause death.
The geographic distribution of the burden of graft failure associated with increased levels of
PM2.5 over 12 μg/m
3 suggests that the highest burden was concentrated in areas with high
population density and a high degree of air pollution, such as the Southwest and East North Central
regions. The map showing areas with increased burden is consistent with that in Goodkind et al,42 in
which the authors illustrated the estimated monetary marginal damages at every emission source
location on a map.42
















0 5.0 7.5 10.0 12.5
Follow-up time, y
2.5

















0 0.50 0.75 1.00
Follow-up time, y
0.25
Baseline PM2.5 level quartile





































0 0.50 0.75 1.00
Follow-up time, y
0.25
Enlarged Kaplan-Meier curves for comparison
Enlarged Kaplan-Meier curves for comparison
Survival curves were adjusted for recipients' age, sex, race and ethnicity, dialysis status and duration, and area deprivation index. PM2.5 indicates fine particulate matter air pollution.
JAMA Network Open | Nephrology Association of Fine Particulate Matter Air Pollution With Kidney Transplant Outcomes
JAMA Network Open. 2021;4(10):e2128190. doi:10.1001/jamanetworkopen.2021.28190 (Reprinted) October 7, 2021 9/16
Downloaded From: https://jamanetwork.com/ by a Washington University - St Louis User  on 10/31/2021
One highlight of this study is the finding that increased PM2.5 concentration was associated with
increased risk of kidney graft failure. This finding is consistent with those in previous reports finding
increased risks for CKD and ESRD among individuals with native kidneys.11,13,43 Additionally, using
multiple definitions of exposures, Bowe et al11 found an association between exposure to PM2.5 and
risk for incident CKD and ESRD in a cohort of US veterans. In an earlier study, Mehta et al13 found that
1-year exposure to increased PM2.5 concentration was associated with an annual decrease in kidney
function. Globally, it was estimated that PM2.5 concentration is associated with 3.3 million cases of
incident CKD and 122.4 million cases of prevalent CKD.43 However, our finding is not supported by
the finding in a Feng et al,44 which found that risk of death-censored graft failure was increased with
increased PM2.5 concentrations, although this change was not statistically significant. This deviation
could be associated with a shorter follow-up time (ie, 2.5-9.5 years in Feng et al44 vs 2-15 years for
analyses using time-dependent exposure and 4.25-17.25 years for analyses using baseline exposure in
this study).
Kidney graft rejection is a major risk factor associated with graft loss.45-47 We found a 13%
increase in odds of rejection within the first year of KT among recipients residing in areas with the
fourth quartile of baseline PM2.5 levels, compared with the first quartile. This finding is consistent
with that in Feng et al44 and suggests an alloimmune etiology as a possible pathway for rejection that
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may be associated with increased risk of graft loss. The exact mechanism of increased risk of
rejection with PM2.5 has not yet been elucidated. We hypothesize that this could be associated with
increased systemic inflammation and activation of the innate and adaptive immune systems. This
hypothesis is based on a growing body of literature suggesting that the organic compounds, free
radicals, and transition metals contained in PM2.5 are associated with increased oxidative stress, as
well as the gene and protein expression of proinflammatory mediators, such as tumor necrosis
growth factor α, monocyte chemoattractant protein 1, macrophage inflammatory protein 2,
interleukin 6, interleukin 1β, and interleukin 8.15,48 Studies have also found that PM2.5 is associated
with increased expression of adhesion molecules like vascular cellular adhesion molecule 1 and the
adhesion of monocyte cells to endothelial cells.49,50 In lung transplant, aryl hydrocarbon receptor is
considered as a pathway to changing naive T cells to inflammatory T helper 17 cells and promoting
chronic inflammation and chronic rejection.51
Our study found a 21% increase in mortality risk among individuals with KTs for every 10 ug/m3
increase in PM2.5 level, similar to the finding of Feng et al (15% increase per 10 ug/m
3 increase in
PM2.5 level).
44 Prior studies among recipients of KTs have found increased risk of cardiovascular
mortality from exposure to air pollutants.25,26 The increased mortality risk has also been reported
among individuals with heart transplants: 26% to 43% increases in mortality risk per 10 ug/m3
increase in time-dependent PM2.5 concentration.
24 In patients with lung transplants, the increase in
mortality risk was not statistically significant, as reported by Bhinder and colleagues,52 possibly
associated with the exposure definition (ie, mean annual PM2.5 concentration from 1996-2010) and
a smaller sample size (ie, approximately 400 individuals). As for mortality among patients with CKD,
it was estimated at 211 019 deaths associated with CKD associated with PM2.5 exposure globally.
43
However, similar to the situation in the general nontransplant population, it is likely that most of
these deaths are associated with detrimental cardiovascular outcomes of PM2.5 exposure.
14,53
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Strengths and Limitations
This study has several strengths. First, to our knowledge, it is one of the first studies on the
association of PM2.5 levels with acute rejection, graft failure, and death in a large national cohort of
individuals with KTs. Second, our analyses benefited from merges of multiple databases to
comprehensively account for potential confounding, including patient, donor, and transplant factors,
as well as contextual characteristics (eg, ADI and population density). Third, multiple exposure
definitions were used to ensure the robustness of study findings. Fourth, the robustness of the
findings was strengthened by sensitivity analyses adjusting for city variations. We note that PM2.5
concentration generally decreased over time. As a consequence, using time-dependent exposure is
particularly important to capture the association of decreasing PM2.5 levels over time with transplant
outcomes. Furthermore, this trend was associated with changes in included recipient and donor
characteristics, transplant factors, and contextual factors, as well as transplant outcomes when
recipients were grouped by baseline PM2.5 level quartiles, as presented in the Table. Patients
receiving KTs in earlier years were more likely to be in the fourth quartile, while patients receiving KTs
in more recent years were more likely to be in the first quartile. To account for these differences, we
used multivariable time-to-event analyses with all relevant factors (including year of KT) included as
covariates. We then chose to report the results using time-dependent exposure as the main findings,
supplemented with results using baseline exposures.
Nonetheless, this study has several limitations that should be noted. First, like most
retrospective studies, the results rely on the accuracy of the recorded data from multiple databases.
Second, although time-dependent analyses allowed for capturing the exposure after KT, the most
updated annual mean PM2.5 concentration was available up to 2018 at the time of the study, limiting
follow-up time. Nonetheless, we were able to include a follow-up of 2 to 15 years. Third, the most
up-to-date residential zip codes for recipients of KTs were recorded at the time of KT. Time-
dependent analyses may be biased if the patients moved to another zip code area after KT. However,
this bias may be decreased if patients who moved after KT were not systematically more likely to
move to areas with higher or lower levels of PM2.5 compared with their area of residence at KT.
Fourth, composition and toxic content of PM2.5 may change over time and by geography;
consequently, use of PM2.5 level alone may underestimate risk.
54 Fifth, indoor air pollution was not
accounted for in this study. Sixth, although we controlled for as many covariates as possible and
adjusted for city variations, residual confounding may remain, which could bias the estimated
association.
Conclusions
To our knowledge, this is one of the first studies in a national cohort of recipients of KTs that found
that increased levels of PM2.5 were independently associated with increased risk of acute rejection,
graft loss, and death. Our findings suggest that efforts toward cleaner air may be associated with
decreased burden of adverse outcomes after KT. In clinical practice, suggesting that recipients of KTs
reside in areas with lower levels of PM2.5 concentration may be associated with improved transplant
outcomes.
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